On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ALLO), a clinical-stage biotechnology company ...

Mercedes-AMG GT 63 S E Performance four-door. Although the team hasn't had the same amount of success since the introduction ...

Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased ...

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...

Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

If you purchased or acquired securities in Caribou between July 14, 2023 and July 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

Allogeneic CAR-T cell therapy (boxes on the right), using donor T cells, can be genetically modified to minimize graft-versus-host disease and immune rejection, offering scalability and faster ...

CARGO Therapeutics, Inc. (NASDAQ: CRGX) recently disclosed key updates regarding its strategic direction, workforce, and financial impacts. The company’s Board of Directors greenlit a decision to ...